L Webster
Overview
Explore the profile of L Webster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Briley P, Webster L, Lankappa S, Pszczolkowski S, McAllister-Williams R, Liddle P, et al.
Npj Ment Health Res
. 2024 Jun;
3(1):32.
PMID: 38937580
Repetitive transcranial magnetic stimulation (rTMS) is an established non-invasive brain stimulation treatment for major depressive disorder, but there is marked inter-individual variability in response. Using latent class growth analysis with...
2.
Briley P, Webster L, Boutry C, Oh H, Auer D, Liddle P, et al.
Psychiatry Res Neuroimaging
. 2024 Jun;
342:111846.
PMID: 38908353
Transcranial magnetic stimulation (TMS) is an FDA-approved neuromodulation treatment for major depressive disorder (MDD), thought to work by altering dysfunctional brain connectivity pathways, or by indirectly modulating the activity of...
3.
Chu F, LaJoie A, Keenan B, Webster L, Langendorf S, Gilmore M
Phys Rev Lett
. 2023 Apr;
130(14):145101.
PMID: 37084442
Collisional plasma shocks generated from supersonic flows are an important feature in many astrophysical and laboratory high-energy-density plasmas. Compared to single-ion-species plasma shocks, plasma shock fronts with multiple ion species...
4.
Briley P, Webster L, Boutry C, Cottam W, Auer D, Liddle P, et al.
Neurosci Biobehav Rev
. 2022 May;
138:104701.
PMID: 35598819
Major depressive disorder (MDD) is frequently co-morbid with anxiety disorders. The co-morbid state has poorer functional outcomes and greater resistance to first line treatments, highlighting the need for novel treatment...
5.
Hurrell A, Beardmore-Gray A, Duhig K, Webster L, Chappell L, Shennan A
BJOG
. 2020 Jul;
127(13):1590-1597.
PMID: 32701207
Despite extensive research, the pathophysiology and prevention of pre-eclampsia remain elusive, diagnosis is challenging, and pre-eclampsia remains associated with adverse maternal and perinatal outcomes. Angiogenic biomarkers, including placental growth factor...
6.
Zhao X, Shah D, Gandhi K, Wei W, Dwibedi N, Webster L, et al.
Osteoarthritis Cartilage
. 2019 Jul;
27(11):1618-1626.
PMID: 31299387
Objective: To estimate the burden of osteoarthritis (OA) among noninstitutionalized adults (≥18 years of age) in the US. Design: Weighted nationally representative data from the 2015 Medical Expenditure Panel Survey...
7.
Webster L, Russell M, Shepherd N, Packer G, Dalgarno E, Neat F
Mar Pollut Bull
. 2018 Mar;
128:456-459.
PMID: 29571396
Polycyclic aromatic hydrocarbons (PAHs) were measured in environmental samples (sponges, fish and sediment) collected in 2014 and 2016 from the Faroe-Shetland Channel and Rosemary Bank Seamount. These data could be...
8.
Shawkat E, Mistry H, Chmiel C, Webster L, Chappell L, Johnstone E, et al.
Pregnancy Hypertens
. 2018 Mar;
11:92-98.
PMID: 29523282
Aim: To compare the blood pressure (BP) lowering effects of labetalol and nifedipine modified release (MR) in hypertensive pregnant women. We also investigated the effect on the heart rate (HR)...
9.
Negretti G, Amin R, Webster L, Egan C
Eye (Lond)
. 2016 Apr;
30(6):873-6.
PMID: 27055673
AimsTo ascertain the effect on visual acuity (VA) of a delay in Hospital Eye Service (HES) consultation for patients referred with proliferative diabetic retinopathy (PDR; R3) from the Diabetic Eye...
10.
Nunez D, Yao X, Lin J, Walker A, Zuo P, Webster L, et al.
Diabetes Obes Metab
. 2016 Mar;
18(7):654-62.
PMID: 26939572
Aims: To investigate the pharmacodynamics, pharmacokinetics and safety/tolerability of blocking reuptake of bile acids using the inhibitor GSK2330672 (GSK672) in patients with type 2 diabetes (T2D). Methods: Subjects with T2D...